A total of 148 novel genomic instability-derived lncRNAs in ccRCC were identified, among which MNX1-AS1 played a critical role in promoting the progression of ccRCC, which may be a potential therapeutic target. This evidence concerns the gene MNX1 and nonpapillary renal cell carcinoma.